NIMG-84. PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RECURRENCE USING MRI AND FET PET

Autor: Michael M Wollring, Jan-Michael Werner, Elena Bauer, Caroline Tscherpel, Philipp Lohmann, Gabriele Stoffels, Christoph Kabbasch, Roland Goldbrunner, Gereon Fink, Karl-Josef Langen, Norbert Galldiks

Publikováno v: Neuro-Oncology. 24:vii184-vii185

BACKGROUND This study evaluates O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET and contrast-enhanced MRI for early response assessment in glioma patients at recurrence treated with lomustine-based chemotherapy. METHODS Thirty-six adult patients with WHO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::793754ebc2259fa232d2460a65b036f0
https://doi.org/10.1093/neuonc/noac209.702

Advances in PET imaging for meningioma patients.

Autor: Galldiks N; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.; Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Düsseldorf, Germany., Albert NL; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Nuclear Medicine, University Hospital of Munich (LMU), Munich, Germany., Wollring M; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany., Werner JM; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany., Lohmann P; Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Villanueva-Meyer JE; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA., Fink GR; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany., Langen KJ; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.; Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany., Tonn JC; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurosurgery, University Hospital of Munich (LMU), Munich, Germany.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2023 Jun 03; Vol. 5 (Suppl 1), pp. i84-i93. Date of Electronic Publication: 2023 Jun 03 (Print Publication: 2023).

Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas.

Autor: Werner JM; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany., Wolf L; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany., Tscherpel C; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany., Bauer EK; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany., Wollring M; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany., Ceccon G; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany., Deckert M; Institute. of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Düsseldorf, Cologne, Germany., Brunn A; Institute. of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Pappesch R; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Goldbrunner R; Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Düsseldorf, Cologne, Germany.; Deptartment of General Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Fink GR; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany., Galldiks N; Deptartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener St. 62, 50937, Cologne, Germany. n.galldiks@fz-juelich.de.; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany. n.galldiks@fz-juelich.de.; Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Düsseldorf, Cologne, Germany. n.galldiks@fz-juelich.de.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2022 Sep; Vol. 159 (2), pp. 309-317. Date of Electronic Publication: 2022 Jun 18.

Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine.

Autor: Ceccon G; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Wollring M; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Brunn A; Department of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Deckert M; Department of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Waldschmidt D; Department of Hepato- and Gastroenterology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, Germany., Fink GR; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Forschungszentrum Jülich, Jülich, Germany., Galldiks N; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Forschungszentrum Jülich, Jülich, Germany.; Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, Germany.

Publikováno v: Case reports in oncology [Case Rep Oncol] 2020 Jan 21; Vol. 13 (1), pp. 35-42. Date of Electronic Publication: 2020 Jan 21 (Print Publication: 2020).